On July 10, 2026, SP Strategic Holdings LLC filed an urgent application for interim relief against InMode Ltd. and its directors in the Haifa District Court. On August 10, 2026, the court denied the petitioners' request for temporary injunctive relief entirely and awarded costs to the respondents. This legal development removes a near-term litigation risk regarding the activist investor's attempt to halt corporate actions. InMode Ltd. operates in the medical aesthetics industry, developing and manufacturing minimally invasive aesthetic devices.

InMode Ltd. reported second quarter 2026 financial results with GAAP revenues of $95.6 million, consistent with the prior year period. Consumables and service revenue increased 13% to $22.3 million, while total cash position stood at $501.1 million as of June 30, 2026. The company completed a share repurchase of 6.38 million ordinary shares for an aggregate price of $87.8 million under its existing program. Management provided full-year 2026 guidance projecting revenues between $365 million and $375 million, non-GAAP gross margins between 74% and 76%, and non-GAAP diluted EPS between $1.29 and $1.34. The filing also notes the appointment of Dr. Shlomo Nass as Chairman and Moshik Itzkovich as Chief Financial Officer effective May 19, 2026. InMode operates in the medical technology industry, developing and marketing minimally invasive radio frequency devices for plastic surgery, dermatology, and other specialties.

InMode Ltd. Special Committee of the Board of Directors has formally commenced its activities to evaluate two acquisition proposals: one from a group including CEO Meir Shamir and another from Steel Partners Holdings L.P. to acquire 100% of the Company. The Committee is acting independently to determine the best course of action for all shareholders. InMode Ltd. operates in the medical technology industry, providing minimally invasive technologies for aesthetic and vascular treatments.

SP Strategic Holdings LLC, an affiliate of Steel Partners Holdings L.P., filed an urgent application in the Haifa District Court on July 10, 2026, seeking interim relief to halt InMode Ltd. and its directors from proceeding with a special committee's evaluation of an acquisition proposal from M.N. Business Strategy Ltd. The application challenges the independence of the company's directors. On July 12, 2026, the Court postponed the hearing and extended the response deadline to July 19, 2026, provided the company agrees not to approve or reject the acquisition proposals before the hearing. InMode Ltd. is a medical technology company that develops and manufactures minimally invasive procedures for aesthetic and health treatments.